Results 61 to 70 of about 6,056 (173)

Regulating risks in pharmaceutical law : the need of an optimal interplay between products safety and products liability [PDF]

open access: yes, 2011
Published online: 7 June 2011The aim of this paper is to call for the need of a theoretical model of pharmaceutical products safety in which the two systems of regulation and liability operate complementarily. The question is why two legal tools that are
RIZZI, Marco
core  

Recent advances: rheumatology [PDF]

open access: yes, 2000
No abstract ...
Madhok, R., Kerr, H., Capell, H.A.
core   +4 more sources

Understanding Cardiovascular Events With JAK Inhibitors: Similarities and Differences of the Vascular Effects Between Different JAK Inhibitors on Endothelial Cells Exposed to Inflammatory Cytokines

open access: yesACR Open Rheumatology, Volume 7, Issue 12, December 2025.
Objective A cardiovascular safety issue has been associated with JAK inhibitors (JAKi). This study compares the effects of distinct approved JAKi on endothelial cell (EC) dysfunction and apoptosis during inflammation. Methods Massive inflammation was induced in human vascular ECs by tumor necrosis factor (TNF) with interleukin‐17A (IL‐17A) treated or ...
Aliki Zavoriti, Pierre Miossec
wiley   +1 more source

Adverse drug reactions induced by cardiovascular drugs in outpatients

open access: yesPharmacy Practice, 2008
Considering increased use of cardiovascular drugs and limitations in pre-marketing trials for drug safety evaluation, post marketing evaluation of adverse drug reactions (ADRs) induced by this class of medicinal products seems necessary.Objectives: To ...
Gholami K, Ziaie S, Shalviri G
doaj  

2024 update on postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia

open access: yesArchives of Medical Science
Introduction Considering lack of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring potential adverse reactions (AEs) to secure a ...
Maciej Banach   +9 more
doaj   +1 more source

The Science of Safety – An Emerging Concept in Medication Use and Research

open access: yesINNOVATIONS in Pharmacy, 2016
Most published reports of patient safety in clinical practice focus largely on the culture of safety in complex health systems, separate from pre-approval and postmarketing research-related safety considerations for drugs, biologics, and other medical ...
Shraddha Shinde, MBA student   +1 more
doaj   +1 more source

Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations [PDF]

open access: yesFarmacia Hospitalaria, 2018
Objective: To know the safety profile of the 4CMenB vaccine in adults in special situations. Method: Security prospective study of phase IV. Inclusion criteria and some vaccination conditions were applied.
María Fernández-Prada   +5 more
doaj   +1 more source

Self-controlled case series with multiple event types [PDF]

open access: yes, 2017
Self-controlled case series methods for events that may be classified as one of several types are described. When the event is non-recurrent, the different types correspond to competing risks.
Douglas, Ian J.   +4 more
core   +1 more source

Completeness of spontaneously reported adverse drug reactions in 4 databases

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 12, Page 3389-3400, December 2025.
Aims To assess the completeness of information provided in adverse drug reaction (ADR) reports in 4 spontaneous report databases. Methods The study was conducted using freely accessible ADR reports from the Canada Vigilance Adverse Reaction Online Database, the US Food and Drug Administration Adverse Event Reporting System (FAERS) database, the UK ...
Mohammed Gebre Dedefo   +5 more
wiley   +1 more source

Drug therapeutic failures as a cause of admission to an intensive care unit at a university hospital

open access: yesJournal of Research in Pharmacy Practice, 2019
Objective: Drug therapeutic failures (TFs) are included in pharmacovigilance reporting, as some authors consider them a type of adverse drug reaction.
Jair Antonio Ruiz-Garzon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy